---
title: Adjuvants for Immunotherapy and Vaccine Development
description: Adjuvants for Immunotherapy and Vaccine Development
image: https://go.technologynetworks.com/hubfs/Technology%20Networks/TN%20Editorial%20Calendar/Article/Merck-MilliporeSigma%20-%20Article%20Sponsorship/June%202021/Merck%20Flyer.png
---

![TechnologyNetwork-test](https://go.technologynetworks.com/hs-fs/hubfs/TechnologyNetwork-test.png?width=512&name=TechnologyNetwork-test.png "TechnologyNetwork-test")

FLYER

# Adjuvants for Immunotherapy and Vaccine Development

![Merck Flyer](https://go.technologynetworks.com/hs-fs/hubfs/Technology%20Networks/TN%20Editorial%20Calendar/Article/Merck-MilliporeSigma%20-%20Article%20Sponsorship/June%202021/Merck%20Flyer%201.png?width=200&name=Merck%20Flyer%201.png "Merck Flyer")

![Merck Flyer](https://go.technologynetworks.com/hs-fs/hubfs/Technology%20Networks/TN%20Editorial%20Calendar/Article/Merck-MilliporeSigma%20-%20Article%20Sponsorship/June%202021/Merck%20Flyer.png?width=400&height=394&name=Merck%20Flyer.png "Merck Flyer")

Whether you specialize in lipidomics, or lipids are a regular part of your research, you will know the critical role they play. For example, adjuvants using heterogeneous monophosphoryl Lipid A (MPL) derived from *Salmonella minnesota* R595, have proven to be safe and effective at inducing Th-1 type immune responses to heterologous proteins in animal and human vaccines. While adjuvant systems play a key part in immunotherapy and vaccine development programs, adjuvant formulation can be a costly and time-consuming process. Partnering with a company with expertise in lipid formulation can help to relieve this burden.

**Download this flyer to discover:**

- Various monophosphoryl lipid A (MPLA) adjuvants
- A trehalose dibehenate and DDA adjuvant system for tuberculosis vaccines

[![Share on Facebook](https://go.technologynetworks.com/hs-fs/hubfs/Images/TN/Landing%20Page%20Template%20Images/Other/FB.png?width=24&name=FB.png)](http://www.facebook.com/share.php?u=https%3A%2F%2Fgo.technologynetworks.com%2Fadjuvants-for-immunotherapy-and-vaccine-development%3Futm_medium%3Dsocial%26utm_source%3Dfacebook) [![Share on LinkedIn](https://go.technologynetworks.com/hs-fs/hubfs/Images/TN/Landing%20Page%20Template%20Images/Other/linkedIn.png?width=24&name=linkedIn.png)](http://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fgo.technologynetworks.com%2Fadjuvants-for-immunotherapy-and-vaccine-development%3Futm_medium%3Dsocial%26utm_source%3Dlinkedin) [![Share on Twitter](https://go.technologynetworks.com/hs-fs/hubfs/Images/TN/Landing%20Page%20Template%20Images/Other/Twitter.png?width=24&name=Twitter.png)](https://twitter.com/intent/tweet?original_referer=https%3A%2F%2Fgo.technologynetworks.com%2Fadjuvants-for-immunotherapy-and-vaccine-development%3Futm_medium%3Dsocial%26utm_source%3Dtwitter&url=https%3A%2F%2Fgo.technologynetworks.com%2Fadjuvants-for-immunotherapy-and-vaccine-development%3Futm_medium%3Dsocial%26utm_source%3Dtwitter&source=tweetbutton&text=Adjuvants%20for%20Immunotherapy%20and%20Vaccine%20Development) [![Share on Email](https://go.technologynetworks.com/hs-fs/hubfs/Images/TN/Landing%20Page%20Template%20Images/Other/email.png?width=24&name=email.png)](mailto:?subject=Check%20out%20https%3A%2F%2Fgo.technologynetworks.com%2Fadjuvants-for-immunotherapy-and-vaccine-development%3Futm_medium%3Dsocial%26utm_source%3Demail%20&body=Check%20out%20https%3A%2F%2Fgo.technologynetworks.com%2Fadjuvants-for-immunotherapy-and-vaccine-development%3Futm_medium%3Dsocial%26utm_source%3Demail)

Technology Networks Limited

Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK

[Email: privacy@technologynetworks.com](mailto:privacy@technologynetworks.com?Subject=Privacy)

© 2021 Technology Networks. All rights reserved

 

![TechnologyNetwork-test](https://go.technologynetworks.com/hs-fs/hubfs/TechnologyNetwork-test.png?width=512&name=TechnologyNetwork-test.png "TechnologyNetwork-test")

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our [Privacy Policy](https://www.technologynetworks.com/tn/privacy)